Melorheostosis

Melorheostosis is a rare, non-hereditary skeletal disorder characterized by irregular, flowing hyperostosis of the cortex of tubular bones. The condition was first described in 1922 by Leri and Joanny, and its name is derived from the Greek words melos (limb), rhein (to flow), and ostosis (condition of the bone).

Epidemiology

Melorheostosis affects both sexes equally and can manifest at any age, although it is typically diagnosed in early adulthood. The prevalence of the condition is estimated to be 0.9 per million.

Pathophysiology

The pathophysiology of melorheostosis is not fully understood. It is believed to be caused by a somatic mutation in the MAP2K1 gene, which leads to increased activity of the MEK1 protein and subsequent hyperostosis. The condition is not inherited but occurs sporadically.

Clinical Presentation

Patients with melorheostosis often present with pain, stiffness, and functional impairment of the affected limb. The condition can also cause deformities and contractures. Radiographically, melorheostosis is characterized by dense, flowing hyperostosis of the cortex of tubular bones, often described as "dripping candle wax" appearance.

Diagnosis

The diagnosis of melorheostosis is primarily based on clinical and radiographic findings. Computed tomography (CT) and magnetic resonance imaging (MRI) can be used to further characterize the lesion and assess the extent of the disease.

Treatment

There is currently no cure for melorheostosis. Treatment is symptomatic and may include pain management, physical therapy, and in some cases, surgery to correct deformities or contractures.

Prognosis

The prognosis of melorheostosis varies depending on the severity and extent of the disease. While the condition is not life-threatening, it can significantly impact the patient's quality of life due to pain and functional impairment.

See Also

• Osteosclerosis
• Osteopathia striata
• Osteopoikilosis

Melorheostosis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia